These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

99 related articles for article (PubMed ID: 32694412)

  • 1. Advanced HIV disease in the Botswana combination prevention project: prevalence, risk factors, and outcomes.
    Lebelonyane R; Mills LA; Mogorosi C; Ussery F; Marukutira T; Theu J; Kapanda M; Matambo S; Block L; Raizes E; Makhema J; Lockman S; Bachanas P; Moore J; Jarvis JN
    AIDS; 2020 Dec; 34(15):2223-2230. PubMed ID: 32694412
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Utility of CD4 count measurement in the era of universal antiretroviral therapy: an analysis of routine laboratory data in Botswana.
    Leeme TB; Mine M; Lechiile K; Mulenga F; Mosepele M; Mphoyakgosi T; Muthoga C; Ngidi J; Nkomo B; Ramaabya D; Tau M; Tenforde MW; Hayes R; Jarvis JN
    HIV Med; 2021 Jan; 22(1):1-10. PubMed ID: 32876378
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Finding, treating and retaining persons with HIV in a high HIV prevalence and high treatment coverage country: Results from the Botswana Combination Prevention Project.
    Bachanas P; Alwano MG; Lebelonyane R; Block L; Behel S; Raizes E; Ussery G; Wang H; Ussery F; Pretorius Holme M; Sexton C; Pals S; Lasry A; Del Castillo L; Hader S; Lockman S; Bock N; Moore J
    PLoS One; 2021; 16(4):e0250211. PubMed ID: 33882092
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Uptake of antiretroviral therapy and male circumcision after community-based HIV testing and strategies for linkage to care versus standard clinic referral: a multisite, open-label, randomised controlled trial in South Africa and Uganda.
    Barnabas RV; van Rooyen H; Tumwesigye E; Brantley J; Baeten JM; van Heerden A; Turyamureeba B; Joseph P; Krows M; Thomas KK; Schaafsma TT; Hughes JP; Celum C
    Lancet HIV; 2016 May; 3(5):e212-20. PubMed ID: 27126488
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Effect of point-of-care CD4 cell count results on linkage to care and antiretroviral initiation during a home-based HIV testing campaign: a non-blinded, cluster-randomised trial.
    Desai MA; Okal DO; Rose CE; Ndivo R; Oyaro B; Otieno FO; Williams T; Chen RT; Zeh C; Samandari T
    Lancet HIV; 2017 Sep; 4(9):e393-e401. PubMed ID: 28579225
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Attrition when providing antiretroviral treatment at CD4 counts >500cells/μL at three government clinics included in the HPTN 071 (PopART) trial in South Africa.
    Bock P; Fatti G; Ford N; Jennings K; Kruger J; Gunst C; Louis F; Grobbelaar N; Shanaube K; Floyd S; Grimwood A; Hayes R; Ayles H; Fidler S; Beyers N;
    PLoS One; 2018; 13(4):e0195127. PubMed ID: 29672542
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Trends in and correlates of CD4+ cell count at antiretroviral therapy initiation after changes in national ART guidelines in Rwanda.
    Mutimura E; Addison D; Anastos K; Hoover D; Dusingize JC; Karenzie B; Izimukwiye I; Mutesa L; Nsanzimana S; Nash D;
    AIDS; 2015 Jan; 29(1):67-76. PubMed ID: 25562492
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Integrated prevention of mother-to-child HIV transmission services, antiretroviral therapy initiation, and maternal and infant retention in care in rural north-central Nigeria: a cluster-randomised controlled trial.
    Aliyu MH; Blevins M; Audet CM; Kalish M; Gebi UI; Onwujekwe O; Lindegren ML; Shepherd BE; Wester CW; Vermund SH
    Lancet HIV; 2016 May; 3(5):e202-11. PubMed ID: 27126487
    [TBL] [Abstract][Full Text] [Related]  

  • 9. High prevalence of distal sensory polyneuropathy in antiretroviral-treated and untreated people with HIV in Tanzania.
    Mullin S; Temu A; Kalluvya S; Grant A; Manji H
    Trop Med Int Health; 2011 Oct; 16(10):1291-6. PubMed ID: 21707880
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Outcomes of the Botswana national HIV/AIDS treatment programme from 2002 to 2010: a longitudinal analysis.
    Farahani M; Vable A; Lebelonyane R; Seipone K; Anderson M; Avalos A; Chadborn T; Tilahun H; Roumis D; Moeti T; Musuka G; Busang L; Gaolathe T; Malefho KC; Marlink R
    Lancet Glob Health; 2014 Jan; 2(1):e44-50. PubMed ID: 25104635
    [TBL] [Abstract][Full Text] [Related]  

  • 11. HIV infection is not associated with the initiation of curative treatment in women with cervical cancer in Botswana.
    Grover S; MacDuffie EC; Wang Q; Bvochora-Nsingo M; Bhatia RK; Balang D; Chiyapo SP; Luckett R; Ramogola-Masire D; Dryden-Peterson SL; Lin LL; Shin SS; Zetola NM
    Cancer; 2019 May; 125(10):1645-1653. PubMed ID: 30801696
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Thirty-day postoperative mortality among individuals with HIV infection receiving antiretroviral therapy and procedure-matched, uninfected comparators.
    King JT; Perkal MF; Rosenthal RA; Gordon AJ; Crystal S; Rodriguez-Barradas MC; Butt AA; Gibert CL; Rimland D; Simberkoff MS; Justice AC
    JAMA Surg; 2015 Apr; 150(4):343-51. PubMed ID: 25714794
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Evolution of late presentation to care and advanced HIV in newly HIV diagnosed subjects in the Republic of Panama: 2012-2017.
    Robles MA; Ortiz AY; Zaldivar Y; Castillo J; Gondola J; Mewa JC; Moreno A; Burgos R; Chavarria O; Castillero O; Gonzalez C; Pascale JM; Martínez AA
    Int J STD AIDS; 2020 Jul; 31(8):791-799. PubMed ID: 32487001
    [TBL] [Abstract][Full Text] [Related]  

  • 14. HIV-associated morbidity and mortality in a setting of high ART coverage: prospective surveillance results from a district hospital in Botswana.
    Barak T; Neo DT; Tapela N; Mophuthegi P; Zash R; Kalenga K; Perry ME; Malane M; Makhema J; Lockman S; Shapiro R
    J Int AIDS Soc; 2019 Dec; 22(12):e25428. PubMed ID: 31850683
    [TBL] [Abstract][Full Text] [Related]  

  • 15. High incidence of tuberculosis in the first year of antiretroviral therapy in the Botswana National antiretroviral therapy programme between 2011 and 2015.
    Mupfumi L; Moyo S; Shin SS; Wang Q; Zetola N; Molebatsi K; Nnawa J; Kgwaadira BT; Bewlay L; Chebani T; Iketleng T; Mogashoa T; Makhema J; Musonda RM; Essex M; Kasvosve I; Gaseitsiwe S
    AIDS; 2019 Dec; 33(15):2415-2422. PubMed ID: 31764106
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Implementation of Universal HIV Testing and Treatment to Reduce HIV Incidence in Botswana: the Ya Tsie Study.
    Lockman S; Holme MP; Makhema J; Bachanas P; Moore J; Wirth KE; Lebelonyane R; Essex M
    Curr HIV/AIDS Rep; 2020 Oct; 17(5):478-486. PubMed ID: 32797382
    [TBL] [Abstract][Full Text] [Related]  

  • 17. HIV Incidence in Botswana Rural Communities With High Antiretroviral Treatment Coverage: Results From the Botswana Combination Prevention Project, 2013-2017.
    Ussery F; Bachanas P; Alwano MG; Lebelonyane R; Block L; Wirth K; Ussery G; Sento B; Gaolathe T; Kadima E; Abrams W; Segolodi T; Hader S; Lockman S; Moore J
    J Acquir Immune Defic Syndr; 2022 Sep; 91(1):9-16. PubMed ID: 35537094
    [TBL] [Abstract][Full Text] [Related]  

  • 18. High CD4 counts associated with better economic outcomes for HIV-positive adults and their HIV-negative household members in the SEARCH Trial.
    Jakubowski A; Snyman K; Kwarisiima D; Sang N; Burger R; Balzer L; Clark T; Chamie G; Shade S; Cohen C; Bukusi E; Charlebois E; Kamya M; Petersen M; Havlir D; Thirumurthy H
    PLoS One; 2018; 13(6):e0198912. PubMed ID: 29944678
    [TBL] [Abstract][Full Text] [Related]  

  • 19. To achieve 95-95-95 targets we must reach men and youth: High level of knowledge of HIV status, ART coverage, and viral suppression in the Botswana Combination Prevention Project through universal test and treat approach.
    Lebelonyane R; Bachanas P; Block L; Ussery F; Alwano MG; Marukutira T; El Halabi S; Roland M; Abrams W; Ussery G; Miller JA; Lockman S; Gaolathe T; Holme MP; Hader S; Mills LA; Wirth K; Bock N; Moore J
    PLoS One; 2021; 16(8):e0255227. PubMed ID: 34375343
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Antiretroviral treatment initiation among HIV-infected pregnant women with low CD4(+) cell counts in Gaborone, Botswana.
    Chen JY; Ogwu AC; Svab P; Lockman S; Moffat HJ; Gaolathe T; Moilwa S; Størdal K; Dryden-Peterson S; Moffat C; Makhema J; Essex M; Shapiro RL
    J Acquir Immune Defic Syndr; 2010 May; 54(1):102-6. PubMed ID: 19864957
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.